BOLT
Bolt Biotherapeutics Inc
Price:  
0.42 
USD
Volume:  
503,592.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BOLT WACC - Weighted Average Cost of Capital

The WACC of Bolt Biotherapeutics Inc (BOLT) is 6.1%.

The Cost of Equity of Bolt Biotherapeutics Inc (BOLT) is 8.55%.
The Cost of Debt of Bolt Biotherapeutics Inc (BOLT) is 5.00%.

Range Selected
Cost of equity 7.10% - 10.00% 8.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.4% - 6.8% 6.1%
WACC

BOLT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.71 0.91
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 10.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.4% 6.8%
Selected WACC 6.1%